MoneyWorks4Me

The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 731.27 millions.Net Profit recorded in the quarter ended June 2024 rise to 46.31% to Rs. 17.47  millions  compared to R. 11.94 millions in corresponding previous quarter.Operating profit surged to 78.86 millions from the corresponding previous quarter of 72.88 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 731.27 701.66 4.22 731.27 701.66 4.22 3385.40 3030.99 11.69
Other Income 8.15 4.48 81.92 8.15 4.48 81.92 33.52 21.92 52.92
PBIDT 78.86 72.88 8.21 78.86 72.88 8.21 357.93 284.92 25.62
Interest 37.05 36.36 1.90 37.05 36.36 1.90 152.35 124.62 22.25
PBDT 41.81 36.52 14.49 41.81 36.52 14.49 205.58 160.30 28.25
Depreciation 20.76 21.22 -2.17 20.76 21.22 -2.17 84.52 74.81 12.98
PBT 21.05 15.30 37.58 21.05 15.30 37.58 121.06 85.49 41.61
TAX 3.58 3.36 6.55 3.58 3.36 6.55 18.34 24.23 -24.31
Deferred Tax -1.90 -2.04 -6.86 -1.90 -2.04 -6.86 10.78 3.92 175.00
PAT 17.47 11.94 46.31 17.47 11.94 46.31 102.72 61.26 67.68
Equity 158.04 156.90 0.73 158.04 156.90 0.73 158.04 156.90 0.73
PBIDTM(%) 10.78 10.39 3.82 10.78 10.39 3.82 10.57 9.40 12.47
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..